NEVANAC is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Nepafenac.
Product ID | 0065-0002_01a34750-69f1-4871-b8cf-1f5bc1badfdf |
NDC | 0065-0002 |
Product Type | Human Prescription Drug |
Proprietary Name | NEVANAC |
Generic Name | Nepafenac |
Dosage Form | Suspension/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2005-09-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021862 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | NEPAFENAC |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2005-09-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021862 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2005-09-06 |
Marketing End Date | 2018-02-09 |
Marketing Category | NDA |
Application Number | NDA021862 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-09-06 |
Ingredient | Strength |
---|---|
NEPAFENAC | 1 mg/mL |
SPL SET ID: | 3ad48650-75e3-4c74-9302-01b0088f164e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0065-0002 | NEVANAC | nepafenac |
0078-0778 | NEVANAC | nepafenac |
0065-1750 | ILEVRO | nepafenac |
0078-0743 | ILEVRO | nepafenac |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEVANAC 78361073 3149473 Live/Registered |
NOVARTIS AG 2004-02-02 |